 |
|
Clinical Research in the United States at a Crossroads
Proposal for a Novel Public-Private Partnership to Establish a National Clinical Research Enterprise
William F. Crowley, Jr, MD;
Louis Sherwood, MD;
Patricia Salber, MD, MBA;
David Scheinberg, MD, PhD;
Hal Slavkin, DDS;
Hugh Tilson, MD, DrPH;
E. Albert Reece, MD, PhD;
Veronica Catanese, MD;
Stephen B. Johnson, PhD;
Adrian Dobs, MD, MHS;
Myron Genel, MD;
Allan Korn, MD;
Nancy Reame, MSN, PhD;
Robert Bonow, MD;
Jack Grebb, MD;
David Rimoin, MD, PhD
JAMA. 2004;291:1120-1126.
The clinical research infrastructure of the United States is currently at a critical crossroads. To leverage the enormous biomedical research gains made in the past century efficiently, a drastic need exists to reengineer this system into a coordinated, safe, and more efficient and effective enterprise. To accomplish this task, clinical research must be transformed from its current state as a cottage industry to an enterprise-wide health care pipeline whose function is to bring the novel research from both government and private entities to the US public. We propose the establishment of a unique public-private partnership termed the National Clinical Research Enterprise (NCRE). Its agenda should consist of informed public participation, supportive information technologies, a skilled workforce, and adequate funding in clinical research. Devoting only 0.25% of the budgets from all health care stakeholders to support the NCRE would permit adequate funding to build the infrastructure required to address these problems in an enterprise fashion. All participants in the US health care delivery system must come together to focus on system-wide improvements that will benefit the public.
Author Affiliations: Harvard Medical School, Director of Clinical Research, Massachusetts General Hospital, Reproductive Endocrine Unit, Boston (Dr Crowley); Medical and Scientif Associates, Limited Liability Corp, Lower Gwynedd, Pa (Dr Sherwood); Blue Shield of California, San Francisco (Dr Salber), University of Southern California School of Dentistry, Los Angeles (Dr Slavkin), and University of California Los Angeles School of Medicine, Cedars-Sinai Medical Center, Los Angeles (Dr Rimoin), Calif; Memorial Sloan-Kettering Cancer Center, New York (Dr Scheinberg), New York University School of Medicine, New York (Dr Catanese), and Columbia University, New York (Dr Johnson), NY; University of North Carolina School of Public Health, Chapel Hill (Dr Tilson); University of Arkansas College of Medicine, Little Rock (Dr Reece); Johns Hopkins University, Baltimore, Md (Dr Dobs); Yale University School of Medicine, Woodbridge, Conn (Dr Genel); Blue Cross/Blue Shield Association (Dr Korn); and Northwestern University, Feinberg School of Medicine (Dr Bonow), Chicago, Ill; University of Michigan School of Nursing, Ann Arbor (Dr Reame); Janssen Research Foundation, Titusville, NJ (Dr Grebb).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Illinois White Paper: Improving the System for Protecting Human Subjects: Counteracting IRB "Mission Creep"
Gunsalus et al.
Qualitative Inquiry 2007;13:617-649.
ABSTRACT
Building Research Programs in Diagnostic Radiology * Part III. Clinical and Translational Research
Thrall
Radiology 2007;243:5-9.
FULL TEXT
Curbing The Cardiovascular Disease Epidemic: Aligning Industry, Government, Payers, And Academics
Califf et al.
Health Aff (Millwood) 2007;26:62-74.
ABSTRACT
| FULL TEXT
NIH support for basic and clinical research: biomedical researcher angst in 2006.
Nathan and Schechter
JAMA 2006;295:2656-2658.
FULL TEXT
Origin and funding of the most frequently cited papers in medicine: database analysis
Patsopoulos et al.
BMJ 2006;332:1061-1064.
ABSTRACT
| FULL TEXT
Protecting Health--The New Research Imperative
Gerberding
JAMA 2005;294:1403-1406.
FULL TEXT
Rekindling Student Interest in Generalist Careers
Schwartz et al.
ANN INTERN MED 2005;142:715-724.
ABSTRACT
| FULL TEXT
|
